{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:33:52Z","timestamp":1792690432806,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001062","name":"Wallace H. Coulter Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ajo.2020.01.032","type":"journal-article","created":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T03:23:27Z","timestamp":1580959407000},"page":"306-319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Diabetic Retinopathy Screening Using a Gold Nanoparticle\u2013Based Paper Strip Assay for the At-Home Detection of the Urinary Biomarker 8-Hydroxy-2\u2032-Deoxyguanosine"],"prefix":"10.1016","volume":"213","author":[{"given":"Dean P.","family":"Hainsworth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abilash","family":"Gangula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"Ghoshdastidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghuraman","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anandhi","family":"Upendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2020.01.032_bib1","series-title":"IDF diabetes atlas, 2000","year":"2000"},{"key":"10.1016\/j.ajo.2020.01.032_bib2","series-title":"IDF diabetes atlas, 2017","year":"2017"},{"key":"10.1016\/j.ajo.2020.01.032_bib3","series-title":"Strengthening health systems to manage diabetic eye disease: integrated care for diabetes and eye health","year":"2017"},{"issue":"5","key":"10.1016\/j.ajo.2020.01.032_bib4","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/archopht.119.5.758","article-title":"Understanding the value of diabetic retinopathy screening","volume":"119","author":"Fong","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2020.01.032_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3949\/ccjm.71.2.151","article-title":"The internist\u2019s role in managing diabetic retinopathy: screening for early detection","volume":"71","author":"Sinclair","year":"2004","journal-title":"Cleve Clin J Med"},{"issue":"6","key":"10.1016\/j.ajo.2020.01.032_bib6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/014107680309600604","article-title":"Screening for diabetic retinopathy","volume":"96","author":"Squirrell","year":"2003","journal-title":"J R Soc Med"},{"issue":"1","key":"10.1016\/j.ajo.2020.01.032_bib7","first-page":"147","article-title":"Report number 6. Design, methods, and baseline results. Report number 7. A modification of the Airlie House classification of diabetic retinopathy. Prepared by the Diabetic Retinopathy Study Group","volume":"21","year":"1981","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ajo.2020.01.032_bib8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0002-9394(76)90292-0","article-title":"Preliminary report on effects of photocoagulation therapy. Diabetic Retinopathy Study Research Group","volume":"81","year":"1976","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2020.01.032_bib9","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1001\/archopht.1979.01020010310003","article-title":"Four risk factors for severe visual loss in diabetic retinopathy: the third report from the Diabetic Retinopathy Study","volume":"97","year":"1979","journal-title":"Arch Ophthalmol"},{"issue":"5 Suppl","key":"10.1016\/j.ajo.2020.01.032_bib10","first-page":"741","article-title":"Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7","volume":"98","year":"1991","journal-title":"Ophthalmology"},{"issue":"5 Suppl","key":"10.1016\/j.ajo.2020.01.032_bib11","first-page":"823","article-title":"Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group","volume":"98","year":"1991","journal-title":"Ophthalmology"},{"issue":"5 Suppl","key":"10.1016\/j.ajo.2020.01.032_bib12","first-page":"766","article-title":"Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group","volume":"98","year":"1991","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2020.01.032_bib13","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4103\/0974-9233.154391","article-title":"Telemedicine in diabetic retinopathy: current status and future directions","volume":"22","author":"Das","year":"2015","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"16","key":"10.1016\/j.ajo.2020.01.032_bib14","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1612836","article-title":"Frequency of evidence-based screening for retinopathy in type 1 diabetes","volume":"376","author":"Nathan","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ajo.2020.01.032_bib15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.17352\/ijcem.000027","article-title":"Diabetic retinopathy: focus on minority populations","volume":"3","author":"Barsegian","year":"2017","journal-title":"Int J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ajo.2020.01.032_bib16","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0002-9394(02)01522-2","article-title":"The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography","volume":"134","author":"Lin","year":"2002","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2020.01.032_bib18","doi-asserted-by":"crossref","first-page":"e0198551","DOI":"10.1371\/journal.pone.0198551","article-title":"Prevalence of diabetic retinopathy and diabetic macular edema in a primary care-based teleophthalmology program for American Indians and Alaskan Natives","volume":"13","author":"Bursell","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ajo.2020.01.032_bib19","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2337\/diacare.28.2.318","article-title":"Addition of primary care\u2013based retinal imaging technology to an existing eye care professional referral program increased the rate of surveillance and treatment of diabetic retinopathy","volume":"28","author":"Wilson","year":"2005","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.ajo.2020.01.032_bib21","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.ophtha.2017.05.026","article-title":"The current state of teleophthalmology in the United States","volume":"124","author":"Rathi","year":"2017","journal-title":"Ophthalmology"},{"issue":"22","key":"10.1016\/j.ajo.2020.01.032_bib22","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1001\/jama.2016.17563","article-title":"Artificial intelligence with deep learning technology looks into diabetic retinopathy screening","volume":"316","author":"Wong","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ajo.2020.01.032_bib23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41746-018-0040-6","article-title":"Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices","volume":"1","author":"Abr\u00e0moff","year":"2018","journal-title":"NPJ Digit Med"},{"issue":"2","key":"10.1016\/j.ajo.2020.01.032_bib24","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ajo.2014.11.008","article-title":"Comparison of smartphone ophthalmoscopy with slit-lamp biomicroscopy for grading diabetic retinopathy","volume":"159","author":"Russo","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2020.01.032_bib25","doi-asserted-by":"crossref","first-page":"e0138285","DOI":"10.1371\/journal.pone.0138285","article-title":"Validation of smartphone based retinal photography for diabetic retinopathy screening","volume":"10","author":"Rajalakshmi","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ajo.2020.01.032_bib26","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/s41433-018-0064-9","article-title":"Automated diabetic retinopathy detection in smartphone-based fundus photography using artificial intelligence","volume":"32","author":"Rajalakshmi","year":"2018","journal-title":"Eye (Lond)"},{"issue":"9","key":"10.1016\/j.ajo.2020.01.032_bib27","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/s41591-018-0107-6","article-title":"Clinically applicable deep learning for diagnosis and referral in retinal disease","volume":"24","author":"De Fauw","year":"2018","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.ajo.2020.01.032_bib28","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.2337\/diacare.26.5.1507","article-title":"Evaluation of urinary 8-hydroxydeoxy-guanosine as a novel biomarker of macrovascular complications in type 2 diabetes","volume":"26","author":"Nishikawa","year":"2003","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.ajo.2020.01.032_bib29","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1177\/112067210801800116","article-title":"Urinary 8-hydroxydeoxyguanosine levels in diabetic retinopathy patients","volume":"18","author":"Dong","year":"2008","journal-title":"Eur J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2020.01.032_bib30","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00125-002-0831-8","article-title":"Urinary excretion of 8-oxo-7, 8-dihydro-2\u2032-deoxyguanosine as a predictor of the development of diabetic nephropathy","volume":"45","author":"Hinokio","year":"2002","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.ajo.2020.01.032_bib31","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/j.bbadis.2015.08.001","article-title":"Oxidative stress, mitochondrial damage and diabetic retinopathy","volume":"1852","author":"Kowluru","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"41","key":"10.1016\/j.ajo.2020.01.032_bib32","doi-asserted-by":"crossref","first-page":"16586","DOI":"10.1073\/pnas.1314575110","article-title":"Photoreceptor cells are major contributors to diabetes-induced oxidative stress and local inflammation in the retina","volume":"110","author":"Du","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.ajo.2020.01.032_bib33","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2337\/diacare.23.2.234","article-title":"Serum markers of oxidative stress and severity of diabetic retinopathy","volume":"23","author":"Hartnett","year":"2000","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.ajo.2020.01.032_bib34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jpba.2004.04.016","article-title":"Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy patients","volume":"36","author":"Xu","year":"2004","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"10.1016\/j.ajo.2020.01.032_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20081386","article-title":"How mitochondria produce reactive oxygen species","volume":"417","author":"Murphy","year":"2009","journal-title":"Biochem J"},{"issue":"11","key":"10.1016\/j.ajo.2020.01.032_bib36","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/j.bbadis.2015.08.001","article-title":"Oxidative stress, mitochondrial damage and diabetic retinopathy","volume":"1852","author":"Kowluru","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"1-2","key":"10.1016\/j.ajo.2020.01.032_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cccn.2003.09.010","article-title":"Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics","volume":"339","author":"Wu","year":"2004","journal-title":"Clin Chim Acta"},{"issue":"1-2","key":"10.1016\/j.ajo.2020.01.032_bib38","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0378-4347(01)00449-2","article-title":"Urinary excretion of 8-hydroxy-2\u2032-deoxyguanosine measured by high-performance liquid chromatography with electrochemical detection","volume":"778","author":"Pilger","year":"2002","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"1","key":"10.1016\/j.ajo.2020.01.032_bib39","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.mrfmmm.2005.01.022","article-title":"DNA repair is responsible for the presence of oxidatively damaged DNA lesions in urine","volume":"574","author":"Cooke","year":"2005","journal-title":"Mutat Res"},{"issue":"9","key":"10.1016\/j.ajo.2020.01.032_bib40","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0161-6420(03)00475-5","article-title":"Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales","volume":"110","author":"Wilkinson","year":"2003","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2020.01.032_bib41","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/archderm.140.12.1520","article-title":"Statistical significance and clinical relevance: the importance of power in clinical trials in dermatology","volume":"140","author":"Bhardwaj","year":"2004","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ajo.2020.01.032_bib42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.sbsr.2016.04.002","article-title":"Various methods of gold nanoparticles (GNPs) conjugation to antibodies","volume":"9","author":"Jazayeri","year":"2016","journal-title":"Sens Biosensing Res"},{"issue":"11","key":"10.1016\/j.ajo.2020.01.032_bib43","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1039\/C4AN00313F","article-title":"A paper electrode integrated lateral flow immunosensor for quantitative analysis of oxidative stress induced DNA damage","volume":"139","author":"Zhu","year":"2014","journal-title":"Analyst"},{"issue":"5","key":"10.1016\/j.ajo.2020.01.032_bib44","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1167\/iovs.07-1206","article-title":"The angiopoietin\/tie-2 system regulates pericyte survival and recruitment in diabetic retinopathy","volume":"49","author":"Cai","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ajo.2020.01.032_bib45","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1463-1326.2007.00795.x","article-title":"Importance of pericytes and mechanisms of pericyte loss during diabetic retinopathy","volume":"10","author":"Ejaz","year":"2007","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"10.1016\/j.ajo.2020.01.032_bib46","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2337\/diabetes.53.4.1104","article-title":"Angiopoietin-2 causes pericyte dropout in the normal retina","volume":"53","author":"Hammes","year":"2004","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.ajo.2020.01.032_bib47","first-page":"343","article-title":"On oedema or cystic disease of the retina","volume":"7","author":"Nettleship","year":"1872","journal-title":"Ophth Hosp Rep"},{"issue":"6","key":"10.1016\/j.ajo.2020.01.032_bib49","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/bjo.2003.018564","article-title":"Babbage the unfortunate","volume":"88","author":"Keeler","year":"2004","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2020.01.032_bib50","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3928\/1542-8877-20050701-14","article-title":"Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration","volume":"36","author":"Rosenfeld","year":"2005","journal-title":"Ophthalmic Surg Lasers Imaging"},{"issue":"4","key":"10.1016\/j.ajo.2020.01.032_bib51","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3928\/1542-8877-20050701-15","article-title":"Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion","volume":"36","author":"Rosenfeld","year":"2005","journal-title":"Ophthalmic Surg Lasers Imaging"},{"issue":"7","key":"10.1016\/j.ajo.2020.01.032_bib53","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.ophtha.2012.03.053","article-title":"Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results","volume":"119","author":"Martin","year":"2012","journal-title":"Ophthalmology"},{"issue":"20","key":"10.1016\/j.ajo.2020.01.032_bib54","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa1102673","article-title":"Ranibizumab and bevacizumab for neovascular age-related macular degeneration","volume":"364","author":"Martin","year":"2011","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ajo.2020.01.032_bib55","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ophtha.2011.12.039","article-title":"Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE","volume":"119","author":"Nguyen","year":"2012","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2020.01.032_bib56","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.ophtha.2014.07.008","article-title":"Vision-related function after ranibizumab treatment for diabetic macular edema: results from RIDE and RISE","volume":"121","author":"Bressler","year":"2014","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ajo.2020.01.032_bib57","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.ophtha.2013.02.034","article-title":"Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE","volume":"120","author":"Brown","year":"2013","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2020.01.032_bib58","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/archophthalmol.2012.1043","article-title":"Long-term effects of ranibizumab on diabetic retinopathy severity and progression","volume":"130","author":"Ip","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2020.01.032_bib59","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.ophtha.2016.03.045","article-title":"Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: the comparison of age-related macular degeneration treatments trials","volume":"123","author":"Maguire","year":"2016","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2020.01.032_bib60","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.ophtha.2018.10.041","article-title":"Durability of diabetic retinopathy improvement with as-needed eanibizumab: open-label extension of RIDE and RISE studies","volume":"126","author":"Sun","year":"2019","journal-title":"Ophthalmology"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939420300507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939420300507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:43:56Z","timestamp":1757598236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939420300507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":56,"alternative-id":["S0002939420300507"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2020.01.032","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetic Retinopathy Screening Using a Gold Nanoparticle\u2013Based Paper Strip Assay for the At-Home Detection of the Urinary Biomarker 8-Hydroxy-2\u2032-Deoxyguanosine","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2020.01.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}